32,947 Shares in Innospec Inc. (NASDAQ:IOSP) Purchased by B. Metzler seel. Sohn & Co. Holding AG

B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in Innospec Inc. (NASDAQ:IOSP) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 32,947 shares of the specialty chemicals company’s stock, valued at approximately $3,726,000.

Other hedge funds have also recently bought and sold shares of the company. Inspire Advisors LLC grew its position in shares of Innospec by 1.6% in the second quarter. Inspire Advisors LLC now owns 6,819 shares of the specialty chemicals company’s stock valued at $843,000 after purchasing an additional 110 shares during the last quarter. Arizona State Retirement System increased its position in Innospec by 1.9% during the 2nd quarter. Arizona State Retirement System now owns 6,962 shares of the specialty chemicals company’s stock worth $860,000 after buying an additional 128 shares during the period. Texas Permanent School Fund Corp lifted its holdings in shares of Innospec by 0.6% during the second quarter. Texas Permanent School Fund Corp now owns 21,891 shares of the specialty chemicals company’s stock worth $2,706,000 after buying an additional 129 shares in the last quarter. Evergreen Capital Management LLC lifted its holdings in shares of Innospec by 8.6% during the second quarter. Evergreen Capital Management LLC now owns 2,421 shares of the specialty chemicals company’s stock worth $299,000 after buying an additional 192 shares in the last quarter. Finally, Creative Planning boosted its position in shares of Innospec by 4.3% in the second quarter. Creative Planning now owns 4,762 shares of the specialty chemicals company’s stock valued at $589,000 after acquiring an additional 195 shares during the period. 96.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut shares of Innospec from a “strong-buy” rating to a “buy” rating in a research note on Thursday, August 8th.

Innospec Trading Up 1.3 %

Shares of IOSP stock opened at $118.25 on Thursday. The stock has a market cap of $2.95 billion, a P/E ratio of 20.64 and a beta of 1.08. Innospec Inc. has a 1 year low of $103.97 and a 1 year high of $133.71. The stock has a 50 day simple moving average of $113.41 and a 200 day simple moving average of $118.75.

Innospec (NASDAQ:IOSP) last released its earnings results on Tuesday, November 5th. The specialty chemicals company reported $1.35 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.35. The firm had revenue of $443.40 million during the quarter, compared to the consensus estimate of $442.13 million. Innospec had a return on equity of 13.33% and a net margin of 7.68%. The company’s revenue was down 4.5% compared to the same quarter last year. During the same period in the prior year, the company posted $1.59 EPS. Analysts forecast that Innospec Inc. will post 5.88 EPS for the current year.

Innospec Increases Dividend

The company also recently disclosed a Semi-Annual dividend, which will be paid on Tuesday, November 26th. Investors of record on Monday, November 18th will be given a dividend of $0.79 per share. This is a boost from Innospec’s previous Semi-Annual dividend of $0.72. The ex-dividend date of this dividend is Monday, November 18th. This represents a yield of 1.3%. Innospec’s dividend payout ratio is currently 26.53%.

Insiders Place Their Bets

In other Innospec news, Director Milton C. Blackmore sold 1,035 shares of the firm’s stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $122.92, for a total value of $127,222.20. Following the sale, the director now owns 9,028 shares of the company’s stock, valued at approximately $1,109,721.76. This trade represents a 10.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Ian Cleminson sold 3,398 shares of the business’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $114.74, for a total value of $389,886.52. Following the transaction, the chief financial officer now directly owns 12,996 shares of the company’s stock, valued at $1,491,161.04. This trade represents a 20.73 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 11,035 shares of company stock worth $1,267,096 over the last ninety days. Corporate insiders own 1.35% of the company’s stock.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.